Search clinical trials for: incretin

Total 1900 results

University Hospital, Angers

Terminated

The Role of Incretins in Bone Remodeling in Humans (INCREMOS)

Healthy | Osteoporosis | Bone Remodeling | Incretins

France
Eli Lilly and Company

Completed

A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide

Obesity | Diabetes Mellitus, Type 2 | Overweight

United States
University at Buffalo
Novo Nordisk A/S

Completed

Liraglutide in the Treatment of Type 1 Diabetes Mellitus

Type 1 Diabetes

United States
Radboud University Medical Center

Active, not recruiting

Visualizing Beta Cells in Patients With a History of Gestational Diabetes

Gestational Diabetes

Netherlands
Novo Nordisk A/S

Completed

Comparison of Two Liraglutide Formulations in Healthy Volunteers

Healthy | Diabetes

Germany
University of Washington
Eli Lilly and Company; Sanofi; Bayer; US Department of Veterans Affairs; University... and other collaborators

Completed

FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR) (FLAT-SUGAR)

Type 2 Diabetes

United States
Takeda

Completed

Treatment Preference for Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Versus Daily DPP-4 Inhibitors in Participants With Type 2 Diabetes Mellitus (TRINITY)

Type 2 Diabetes Mellitus

Japan
University College, London

Active, not recruiting

Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease (Exenatide-PD3)

Parkinson's Disease

United Kingdom
Boehringer Ingelheim

Active, not recruiting

Esgliteo Post Marketing Surveillance (PMS) in Korean Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Korea, Republic of
St Vincent's University Hospital, Ireland
University College Dublin; Health Research Board, Ireland

Completed

Effect of Liraglutide vs CPAP on Cardiometabolic Outcomes in Obstructive Sleep Apnea

Sleep Apnea, Obstructive

Ireland
University of Palermo

Completed

Effects of Degludec/Liraglutide on Time in Range, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic Inpatients

Diabetes Mellitus, Type 2

Italy
Weill Cornell Medical College in Qatar
University of Hull; Hamad Medical Corporation; Sidra Medical and Research Center

Active, not recruiting

HbA1c Variability in Type II Diabetes

Diabetes Mellitus Type 2

Qatar
Takeda

Completed

An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus (TRACK)

Type 2 Diabetes Mellitus

Japan
Takeda

Completed

Double-blind Comparative Study of SYR-472

Diabetes Mellitus

Japan
Turku University Hospital

Active, not recruiting

Liraglutide in the Prevention of Type 2 Diabetes After Gestational Diabetes (Liragest)

Gestational Diabetes

Finland
Texas Tech University
Novo Nordisk A/S

Completed

To Predict Weight Loss Response to Liraglutide (Saxenda®), From fMRI-based Determination of Food Cue Reactivity

Obesity

United States
Xinqiao Hospital of Chongqing
University of Messina; Azienda Ospedaliera Universitaria Policlinico "G. Martino...

Completed

The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS

Obesity | Overweight | Polycystic Ovary Syndrome (PCOS)

China
Boehringer Ingelheim

Completed

DIA_CENTRAL:T2D Treatment Pattern in Central Europe

Diabetes Mellitus, Type 2

Bulgaria, Czechia, Hungary, Poland, Russian Federation
RenJi Hospital

Terminated

Efficacy and Safety of Empagliflozin in NODAT

Kidney Transplant; Complications | New Onset Diabetes After Transplant

China
David D'Alessio, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Incretin Action in Physiology and Diabetes

Insulin Secretion

United States
Rigshospitalet, Denmark

Active, not recruiting

GLP-1 and Hyperoxia for Organ Protection in Heart Surgery (GLORIOUS)

Stroke | Coronary Disease | Brain Injury | Aortic Valve Disease | Renal Failure | Shock, Cardiogenic

Denmark
Galenicum Health

Completed

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.

Diabetes Mellitus, Type 2 | Bioequivalence

Mexico
Galenicum Health

Completed

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.

Diabetes Mellitus, Type 2 | Bioequivalence

Mexico
Galenicum Health

Completed

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.

Diabetes Mellitus, Type 2 | Bioequivalence

Mexico
Galenicum Health

Completed

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.

Diabetes Mellitus, Type 2 | Bioequivalence

Mexico
Ain Shams University
Ahram Canadian University

Completed

The Impact of Sitagliptin as an Add on Therapy With Closed Loop Control in Adolescents With Diabetic Nephropathy

Type 1 Diabetic Nephropathy

Egypt
Novo Nordisk A/S

Completed

Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Denmark
Eli Lilly and Company

Completed

A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)

Type 2 Diabetes

United States, Puerto Rico, Spain, Germany, Argentina, Brazil, Turkey, Hungary, Italy, Russian Federation, Slovakia, Belgium, Czechia, Greece, Mexico, Romania
Novo Nordisk A/S

Completed

Safety and Tolerability of Liraglutide in Healthy Volunteers and Subjects With Type 2 Diabetes

Healthy | Diabetes Mellitus, Type 2 | Diabetes

United Kingdom
AstraZeneca

Completed

Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP) (HARRP)

Type 2 Diabetes Mellitus

Sweden
Population Health Research Institute
Novo Nordisk A/S

Completed

Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLira (REMITiDegLira)

Type 2 Diabetes Mellitus

Canada
University of Copenhagen
Rigshospitalet, Denmark; Bispebjerg Hospital

Completed

Development and Evaluation of a Glucagon Sensitivity Test in Individuals With and Without Hepatic Steatosis (GLUSENTIC)

Obesity | Type 1 Diabetes | Non-Alcoholic Fatty Liver Disease | Glucagon Resistance

Denmark
University of North Carolina, Chapel Hill
Novo Nordisk A/S

Completed

Efficacy of Liraglutide Therapy in Patients With IPAA

Pouchitis | Irritable Pouch Syndrome

United States
University Hospital, Gentofte, Copenhagen

Completed

Incretin Effect in Patients With Psoriasis and Controls

Psoriasis Vulgaris
Mayo Clinic
Patient-Centered Outcomes Research Institute

Active, not recruiting

Second-line Therapies for Patients With Type 2 Diabetes and Moderate Cardiovascular Disease Risk

Type 2 Diabetes | Cardiac Disease

United States
Novo Nordisk A/S

Completed

A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 Diabetes (PIONEER 12)

Diabetes Mellitus, Type 2

Serbia, South Africa, Taiwan, Romania, Algeria, Hong Kong, Brazil, China, Czechia
Takeda

Completed

Comparative Study to Evaluate Efficacy and Safety When Metformin Hydrochloride 500 mg Once Daily is Added on to SYR-322 25 mg in Type 2 Diabetic Patients With Inadequate Glycemic Control Despite Treatment With SYR-322 25 mg in Addition to Diet and Exercise Therapy

Type 2 Diabetes Mellitus

Japan
The University of Texas Health Science Center at...
South Texas Veterans Health Care System

Active, not recruiting

Effect of Physiologic Hyperglucogonemia on Adipocyte Metabolism (Glucagon)

Insulin Sensitivity

United States
Hospital de Especialidades, Centro Medico Nacional...
National Polytechnic Institute, Mexico

Completed

SITAgliptin Plus GLARgine to Glycemic Control in the Hospital Setting (SITAGLAR-H) (SITAGLAR-H)

Type 2 Diabetes

Mexico
Rebecca Ashare
Novo Nordisk A/S

Completed

Daily Liraglutide for Nicotine Dependence (DAL)

Smoking Cessation | Weight, Body

United States
Hospital Universitari de Bellvitge
Instituto de Salud Carlos III

Enrolling by invitation

Diabetes Remission and Hypoabsorptive Bariatric Surgery (DIABAR-3)

Diabetes Mellitus, Type 2 | Bariatric Surgery Candidate | Severe Obesity

Spain
Virginia Polytechnic Institute and State University
The Hershey Company

Completed

Cocoa and Metabolic Health in Prediabetes

Prediabetes

United States
Takeda

Completed

Effect of Food on the Pharmacokinetics of Single Oral Dose Administration of a Fixed-Dose Combination of SYR-322 and Metformin Hydrochloride in Healthy Adult Male Subjects

Clinical Pharmacology

Japan
Takeda

Completed

Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Amgen

Completed

Multiple Ascending Dose Study of AMG 598 in Adults With Obesity

Obesity

United States
Eli Lilly and Company

Completed

A Study of LY3437943 in Participants Who Have Obesity or Are Overweight

Obesity | Overweight

United States, Puerto Rico
University of Nebraska

Terminated

Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation

End Stage Renal Disease | Type 2 Diabetes

United States
Takeda

Completed

Specified Drug-Use Survey of Alogliptin and Metformin Hydrochloride Combination Tablets "Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Renal or Hepatic Impairment or Advanced Age"

Type 2 Diabetes Mellitus

Japan
Boehringer Ingelheim

Completed

Evaluating Comparative Effectiveness of Empagliflozin in Type 2 Diabetes Population With and Without Chronic Kidney Disease

Diabetes Mellitus, Type 2

United States
Emory University
Novo Nordisk A/S

Completed

IDegLira HIGH Trial

Diabetes Mellitus

United States

Search clinical trials for: incretin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations